Chemistry International Blank Image
Chemistry International Text Image Link to Chemistry International Blank Image Chemistry International Blank Image Chemistry International Blank Image
Chemistry International Blank Image
Chemistry International Blank Image
Chemistry International Text Image Link to Current Issue
Chemistry International Text Image Link to Past Issues
Chemistry International Text Image Link to Officer's Columns
Chemistry International Text Image Link to Features
Chemistry International Blank Image
Chemistry International Text Image Link to Up for Discussion
Chemistry International Text Image Link to IUPAC Wire
Chemistry International Text Image Link to Project Place
Chemistry International Text Image Link to imPACt
Chemistry International Text Image Link to Bookworm
Chemistry International Text Image Link to Internet Connections
Chemistry International Text Image Link to Conference Call
Chemistry International Text Image Link to Where 2B and Y
Chemistry International Text Image Link to Symposia
Chemistry International Text Image Link to CI Indexes
Chemistry International Text Image Link to CI Editor
Chemistry International Text Image Link to Search Function
Chemistry International Text Image Link to Information

 

Chemistry International Text Image Link to Previous Issue Chemistry International Text Image Link to Previous Page Chemistry International Text Image Link to This TOC Chemistry International Text Image Link to Next Page Chemistry International Text Image Link to Next Issue

Vol. 28 No. 1
January-February 2006

IUPAC Wire | News and information on IUPAC, its fellows, and members organizations
See also www.iupac.org/news

Two New CAs Join IUPAC

Two industrial companies from the United Kingdom have joined IUPAC as Company Associates. AstraZeneca R&D Charnwood and Syngenta will now take part, with more than 100 companies from around the world, in the work of the Committee on Chemistry and Industry to influence the IUPAC agenda.

The United Kingdom is one of the major hubs of AstraZeneca—one of the world’s leading pharmaceutical companies. The company’s Charnwood site is focused on finding new medicines for respiratory diseases such as asthma, chronic bronchitis, and emphysema (diseases often associated with smoking and for which new medicines are desperately needed) as well as inflammatory diseases such as rheumatoid and osteoarthritis.

Syngenta’s Jealott’s Hill, established in 1927, is a center of excellence for discovery and bio-performance research and is a key site for environmental sciences. It is the company’s largest research site, employing over 800 scientists and support staff. Jealott’s Hill houses the company’s main collection of hundreds of thousands of chemical compounds. Over 200 000 chemicals are added to the collection from a variety of sources each year. It is also the Syngenta global center for environmental sciences and works closely with Syngenta CTL to ensure all products are tested for safety in the environment.

AstraZeneca R&D Charnwood
Dr. John Dixon <john.dixon@astrazeneca.com>
Vice President; Drug Discovery
<www.astrazeneca.com>

Syngenta
Jeollot’s Hill International Research Station
Bracknell, Berkshire
Dr. Paul Worthington <paul.worthington@syngenta.com>
<www.syngenta.co.uk/about/syngenta-jealotts-hill.asp>

www.iupac.org/links/ca.html


Page last modified 6 January 2006.
Copyright © 2003-2006 International Union of Pure and Applied Chemistry.
Questions regarding the website, please contact edit.ci@iupac.org
Link to CI Home Page Link to IUPAC E-News Link to IUPAC Home Page